Inneke Van De Vijver
Biographic Data
| ID | 9570336 |
|---|---|
| NAME | Inneke Van De Vijver |
| GIVEN NAMES | Inneke |
| FAMILY NAME | Van De Vijver |
| SIGNATURE | VAN DE VIJVER I |
| AFFILIATIONS | Rijksinstituut voor Ziekte- en Invaliditeitsverzekering |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Availability and financing of CAR-T cell therapies
Chimeric antigen receptor T-cell therapies (CAR-T therapies) are a type of advanced therapy medicinal product (ATMP) that belong to a new generation of personalised cancer immunotherapies. This paper compares the approval, availability and financing of CAR-T cell therapies in ten countries. It also examines the implementation of this type of ATMP within the health care system, describing the organizational elements of CAR-T therapy delivery and t…
No prominent works on this page.
Availability and financing of CAR-T cell therapies
Chimeric antigen receptor T-cell therapies (CAR-T therapies) are a type of advanced therapy medicinal product (ATMP) that belong to a new generation of personalised cancer immunotherapies. This paper compares the approval, availability and financing of CAR-T cell therapies in ten countries. It also examines the implementation of this type of ATMP within the health care system, describing the organizational elements of CAR-T therapy delivery and t…
Biomedical Ethics and Regulation (1 works) · Biosimilars and Bioanalytical Methods (1 works) · Business (1 works) · CAR-T cell therapy research (1 works) · Finance (1 works)